Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds

NCT00564213 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

High Myopia

Interventions

DRUG: PRK and a single intraoperative topical application of mitomycin C 0.02% for 15 seconds

Sponsor

Instituto de Olhos de Goiania